Left Menu
Development News Edition

J&J pauses COVID-19 vaccine trials due to unexplained illness in participant

In September, the British group paused late-stage trials of its experimental coronavirus vaccine, developed with the University of Oxford, due to an unexplained illness in a British study participant. Last month, J&J said its experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial.

Reuters | Updated: 13-10-2020 13:57 IST | Created: 13-10-2020 13:57 IST
J&J pauses COVID-19 vaccine trials due to unexplained illness in participant

Johnson & Johnson said on it had temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, delaying one of the highest profile efforts to contain the global pandemic.

The participant's illness is being reviewed and evaluated by an independent data and safety monitoring board as well as the company's clinical and safety physicians, the company said https://www.jnj.com/our-company/johnson-johnson-temporarily-pauses-all-dosing-in-our-janssen-covid-19-vaccine-candidate-clinical-trials in a statement. J&J, which reports quarterly financial results on Tuesday morning, said that such pauses are normal in big trials, which can include tens of thousands of people. It said the "study pause" in giving doses of the vaccine candidate was different from a "regulatory hold" required by health authorities. The current case is a pause.

However, J&J's move follows a similar one by AstraZeneca . In September, the British group paused late-stage trials of its experimental coronavirus vaccine, developed with the University of Oxford, due to an unexplained illness in a British study participant. Both candidates are based on a so-called adenovirus, a harmless modified virus that instructs human cells to produce vaccine proteins, and both are part of the U.S. government's Operation Warp Speed programme to support vaccine development.

"This could be a second case of adenoviral vaccine to spur safety concerns," said Bryan Garnier analyst Olga Smolentseva. J&J on Sept. 22 became the fourth Warp-Speed participant to enter the final stage of testing on humans, with the aim of enrolling 60,000 volunteers in the United States and abroad.

While Astra's trials in Britain, Brazil, South Africa and India have resumed, the U.S. trial is still on hold, pending a regulatory review. Dr. William Schaffner, a professor of infectious diseases at the Vanderbilt University School of Medicine, said by email that "Everybody is on the alert because of what happened with AstraZeneca," adding that it could take a week to gather information.

"It would have to be a serious adverse event. If it was something like prostate cancer, uncontrolled diabetes or a heart attack - they wouldn't stop it for any of those reasons. This is likely to be a neurological event," he said. Last month, J&J said its experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial. This prompted the company to start the large scale trial, with results expected by the end of this year or early 2021.

J&J declined to elaborate on the illness due to privacy concerns. It did say that some participants in studies get placebos, and it was not always clear whether a person suffering a serious adverse event in a clinical trial received a placebo or the treatment. Stat News reported https://www.statnews.com/2020/10/12/johnson-johnson-covid-19-vaccine-study-paused-due-to-unexplained-illness-in-participant/?utm_content=buffer37312&utm_medium=social&utm_source=twitter&utm_campaign=twitter_organic the pause earlier in the day citing a document sent to outside researchers, which stated that a "pausing rule" had been met, the online system used to enroll patients in the study had been closed and the data and safety monitoring board would be convened.


TRENDING

OPINION / BLOG / INTERVIEW

Turbulence surrounding tobacco control in Ghana

... ...

Refugee compassion and response: Ideas to mitigate disasters now and in their future

Their homeland becomes a forbidden territory for them and more likely than not, their journey to foreign soil is no less traumatizing, not to say deadly. It is crucial to help refugees live a life of dignity and purpose....

Inadequate water infrastructure causes a tidal wave of coronavirus in rural Alaska

... ...

Videos

Latest News

Kerala reports 5,375 new COVID-19 cases

Kerala reported 5,375 new cases of COVID -19 and 26 deaths in the last 24 hours.According to the data released by the state government, 6,151 patients recovered today and total recoveries have gone up to 5, 44,864.The state has 61,092 act...

COVID-19 can spark new generation of social protection measures: UN chief

Antnio Guterres was speaking at an event to commemorate the 25th anniversary of the World Summit for Social Development, where he called for bold and imaginative action by leaders to avert the long-term impacts of the crisis. The pandemic...

Now Sabarimala Prasadam for devotees at their doorstep via Speed Post

Department of Posts has decided to deliver Sabarimala Swami Prasadam to devotees across the country at their doorstep. According to the official press release on Tuesday, Keeping in view devotees across the country, Department of Posts conc...

Delhi Minister Gehlot, AAP leader Atishi extend support to protesting farmers

Delhi Minister Kailash Gehlot on Tuesday visited Burari, a designated protest site for farmers in the national capital while Aam Aadmi Party AAP leader Atishi visited Singhu border Delhi-Haryana to extend their support to the protesting far...

Give Feedback